Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of Genius Sports Limited (NYSE: GENI) closed at $12.22 in the last session, up 1.16% from day before closing price of $12.08. In other words, the price has increased by $1.16 from its previous closing price. On the day, 9.92 million shares were traded. GENI stock price reached its highest trading level at $12.36 during the session, while it also had its lowest trading level at $11.7071.
Ratios:
We take a closer look at GENI’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.19 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 81.25. For the most recent quarter (mrq), Quick Ratio is recorded 1.42 and its Current Ratio is at 2.32. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Northland Capital on July 25, 2025, initiated with a Outperform rating and assigned the stock a target price of $14.
On July 09, 2025, Arete started tracking the stock assigning a Buy rating and target price of $15.
On July 01, 2025, Truist started tracking the stock assigning a Buy rating and target price of $14.Truist initiated its Buy rating on July 01, 2025, with a $14 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 13 ’25 when Burns Daniel Paul bought 8,157 shares for $10.45 per share.
Stevens Eric bought 79,373 shares of GENI for $744,519 on Mar 06 ’25. On Jan 17 ’25, another insider, Davison Jack, who serves as the Officer of the company, bought 100,388 shares for $8.74 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GENI now has a Market Capitalization of 2894624768 and an Enterprise Value of 2681211136. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.81 while its Price-to-Book (P/B) ratio in mrq is 4.51. Its current Enterprise Value per Revenue stands at 5.01 whereas that against EBITDA is -92.331.
Stock Price History:
The Beta on a monthly basis for GENI is 1.86, which has changed by 0.8571428 over the last 52 weeks, in comparison to a change of 0.21149921 over the same period for the S&P500. Over the past 52 weeks, GENI has reached a high of $12.44, while it has fallen to a 52-week low of $5.76. The 50-Day Moving Average of the stock is 18.89%, while the 200-Day Moving Average is calculated to be 28.82%.
Shares Statistics:
According to the various share statistics, GENI traded on average about 5.31M shares per day over the past 3-months and 6245600 shares per day over the past 10 days. A total of 239.82M shares are outstanding, with a floating share count of 215.34M. Insiders hold about 10.20% of the company’s shares, while institutions hold 89.17% stake in the company. Shares short for GENI as of 1752537600 were 28984049 with a Short Ratio of 5.46, compared to 1749772800 on 16392491. Therefore, it implies a Short% of Shares Outstanding of 28984049 and a Short% of Float of 13.389999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
